Crossbeta Biosciences B.V.
Records under this name other than patents Crossbeta Biosciences B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Crossbeta Biosciences B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,104,725 | Amyloid beta oligomer specific binding molecule Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,498,147 | Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases Lapsed on the fee record Ended Mar 3, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 3, 2021 | From the USPTO record |
| US 8,158,585 | Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity Formerly held Lapsed on the fee record Ended Apr 17, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2020 | From the USPTO record |
| US 8,114,832 | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition Lapsed on the fee record Ended Feb 14, 2020 · From the USPTO record | Lapsed on the fee record | Ended Feb 14, 2020 | From the USPTO record |
| US 8,067,187 | Cross-β structure binding compounds Lapsed on the fee record Ended Nov 29, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 29, 2019 | From the USPTO record |